6th CKD Drug Development Summit 2024

Advance More Personalized Therapies for Rare and Common Kidney Diseases
The surge of clinical breakthroughs in SGLT2s, GLP-1s and ERAs for CKD, significant advancements to strengthen proteinuria and GFR slope as surrogates for long-term outcomes, and a wave of promising new targets in development, has truly lit the fuse on decades of innovative kidney research.

Bringing together 200+ biopharma stakeholders, from scientific research to clinical development and outcomes, across three days of concentrated discussion, the 6th CKD Drug Development Summit is the definitive forum for KOLs, industry experts, and regulators to concentrate kidney innovation onto the next generation of drug development.

Time: 8:00 AM – 5:00 PM

Venue details: Hilton Boston Back Bay, 40 Dalton Street, Boston, Massachusetts, 02115, United States

Prices: USD 2999.00 – USD 5846.00

Speakers: Achim Obergfell, Global Medical Head Nephrology, CSL Vifor, Aliza Thompson, Deputy Director, Division of Cardiology and Nephrology, FDA, Amit Sharma, Vice President Clinical Development – Global Therapeutic Area Head Nephrology and Hematology, Alexion Pharmaceuticals, Anil Karihaloo, Senior Principal Research Scientist, Novo Nordisk, Ankit Patel, Associate Medical Director, Vertex Pharmaceuticals, and more